Search Within

Jennifer Jean Mueller

  1. "Early Drug Development Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (6)
  2. Early Drug Development Service (6)
  3. GDMT, Surgery (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. Surgery (6)

More Groups

People
  1. Carol Aghajanian (5)
  2. Claire Friedman (4)
  3. David Hyman (4)
  4. Mario Leitao (4)
  5. Vicky Makker (4)
  6. Britta Weigelt (3)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2016 (1)
Publications
  1. Clinical Cancer Research (1)
  2. Gynecologic Oncology (1)
  3. International Journal of Gynecological Cancer (1)
  4. JCO Precision Oncology (1)
  5. Journal of Clinical Oncology (1)
  6. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
    Journal Article

    Stasenko, M.; Tunnage, I.; Ashley, C. W.; Rubinstein, M. M.; Latham, A. J.; Da Cruz Paula, A.; Mueller, J. J.; Leitao, M. M. Jr; Friedman, C. F.; Makker, V.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Staging lymphadenectomy in patients with clear cell carcinoma of the ovary
    Journal Article

    Mueller, J. J.; Holzapfel, M.; Han, C. H.; Santos, K.; Gunderson, C.; Moore, K.; Erickson, B.; Leath, C. A.; Diaz, E.; Walsh, C.; more...
    International Journal of Gynecological Cancer (2016)

    Fulltext@MSK | Save